CFTR and cystic fibrosis: Therefore, new CFTR modulator drugs that have shown great promise in restoring CF-related pulmonary and pancreatic deficiencies in patients with CF may be repurposed for use in the treatment of CFTR-deficient GI cancers in both patients with CF and in patients without CF.